Skip to NavigationSkip to content

News

Aveo Oncology has hit another hurdle in its quest for approval of its VEGFR-TKI tivozanib for the treatment of highly refractory metastatic renal...
Halozyme Therapeutics has announced it is to cull its workforce by more than half in the wake of the news that its investigational candidate...
Takeda has announced it is divesting a portfolio of its over-the-counter (OTC) and prescription drug products to Stada for a total value of $660...
The FDA has authorised the availability of Sandoz’s Ziextenzo (pegfilgrastim-bmez), a biosimilar version of Amgen’s Neulasta, it has emerged.
Sanofi’s quadrivalent influenza vaccine Fluzone High Dose has secured FDA approval in adult patients over the age of 65 for the prevention of two A...
RedHill Biopharma is celebrating after the FDA chose to award marketing authorisation to Talicia (omeprazole magnesium, amoxicillin and rifabutin)...
With the release of its Q3 financial results, AbbVie confirmed that international revenues for its blockbuster therapy Humira (adalimumab) – the...
The US FDA could be set to receive its next long-term Commissioner after the White House revealed President Donald Trump’s top pick to lead the...
Shanghai Green Valley Pharmaceuticals has announced that its therapy Oligomannate (GV-971) has secured marketing approval from China's ...
Sanofi took the opportunity at the International Society for Pediatric and Adolescent Diabetes 45th Annual Conference in Boston, Massachusetts to...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches